An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

NCT06923891 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
172
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vanguard Research Group

Collaborators